Teva nears restart of CA plant; Packaging miscommunication has big price;

> Teva expects to restart production at its Irvine, CA, plant next month, following a remediation effort prompted by a December 2009 warning letter. Story

> Life sciences artwork management firm Kallik says that human error and incomplete product data have a big effect on production; poor coordination between the creative and technical sides of the house lengthens review cycles and generates unnecessary rework. Article

> An RFID pilot for track and trace at the item, pack and pallet level has been completed by Argentinean drugmaker Laboratorios Gador. Story

> CMO ScinoPharm in Taiwan will make vilazodone hydrochloride, the active ingredient in Clinical Data's just approved antidepressant, Viibryd. Item

> High tech electronics may provide a role model for the biopharma supply chain. Column

> The U.S. Trade and Development Agency is organizing a two-week trade mission to connect Indian drug executives and officials with U.S. cold chain suppliers and manufacturers. Article

> Contract manufacturer Helix plans to begin construction of a manufacturing plant in Costa Rica. Story

> Felten has designed and built a manufacturing facility for Czech-based Lonza Biotec, boosting fermentation capacities by 50 percent. Story